GSK8814 ( GSK 8814;GSK-8814 )

Catalog No. M13118 CAS No. 1997369-78-4

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

GSK8814
Note

Research use only, not for human use.
Brief Description

GSK8814 is a potent, selective inhibitor of ATAD2/2B bromodomain binding constant pKd of 8.1 in ITC assays.
Description

GSK8814 is a potent, selective inhibitor of ATAD2/2B bromodomain binding constant pKd of 8.1 in ITC assays; displaces acetylated H4 peptide from the ATAD2 bromodomain with pIC50 of 7.3 and is also active in BROMOscan with pKi of 8.9, displays >100 fold selective over all other bromodomains and >1,000 fold selective over BRD4; shows cellular target engagement with an EC50 of 2 μM in a NanoBRET assay evaluating the interaction of the NanoLuc-ATAD2 bromodomain with histone H3.3-HaloTag.
Synonyms

GSK 8814;GSK-8814
Pathway

Chromatin/Epigenetic
Target

Bromodomain
Recptor

Bromodomain
Research Area

——
Indication

——

CAS Number

1997369-78-4
Formula Weight

527.62
Molecular Formula

C28H35F2N5O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(C(N1)=O)=CC2=C1C(N[C@H]3[C@H](OCC4CCC(F)(F)CC4)CNC[C@@H]3OC)=NC=C2C5=CN=CC(C)=C5
Chemical Name

8-(((3R,4R,5S)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one